Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM N.V.    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Amsterdam
05/27/2020 05/28/2020 05/29/2020 06/01/2020 06/02/2020 Date
113.5(c) 116(c) 115.05(c) 115.1(c) 116.9 Last
487 900 472 463 1 345 114 220 446 294 837 Volume
+1.16% +2.20% -0.82% +0.04% +1.56% Change
More quotes
Financials
Sales 2020 8 956 M 9 964 M 9 964 M
Net income 2020 756 M 841 M 841 M
Net Debt 2020 2 118 M 2 356 M 2 356 M
P/E ratio 2020 26,2x
Yield 2020 2,16%
Sales 2021 9 426 M 10 487 M 10 487 M
Net income 2021 889 M 989 M 989 M
Net Debt 2021 1 778 M 1 978 M 1 978 M
P/E ratio 2021 22,6x
Yield 2021 2,24%
Capitalization 19 541 M 21 743 M 21 740 M
EV / Sales 2020 2,42x
EV / Sales 2021 2,26x
Nbr of Employees 21 866
Free-Float 94,7%
More Financials
Company
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions)... 
Sector
Diversified Chemicals
Calendar
08/04 | 01:00amEarnings Release
More about the company
Surperformance© ratings of Royal DSM N.V.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROYAL DSM N.V.
01:41aROYAL DSM N : DSM introduces Again™, commercial carpet designed for circul..
PU
05/19ROYAL DSM N : Open collaborative platform UNITE4COVID launched to accelerate Cov..
PU
05/13ROYAL DSM : Presentation to AGM
PU
05/12ROYAL DSM : Ex-dividend day for final dividend (optional)
FA
05/11ROYAL DSM : DSM boosts maternal and infant nutrition portfolio with new plant-ba..
PU
05/08ROYAL DSM : Final dividend 2019 Royal DSM
PU
05/08ROYAL DSM : DSM announces results of 2020 Annual General Meeting of Shareholders
PU
05/08ROYAL DSM : Annual General Meeting of Shareholders 2020
PU
05/08ROYAL DSM : Dividends
CO
05/08ROYAL DSM : Proxy Statments
CO
05/07GLOBAL MARKETS LIVE: Merger between 02 and Virgin goes ahead
05/07ROYAL DSM : DSM reports in-line quarterly results, suspends outlook
RE
05/07ROYAL DSM : DSM reports Q1 2020 results
PU
05/07ROYAL DSM : 1st quarter results
CO
05/04ROYAL DSM : quaterly earnings release
More news
News in other languages on ROYAL DSM N.V.
01:41aROYAL DSM N : DSM introduces Again™, commercial carpet designed for circul..
05/19ROYAL DSM N : Open collaborative platform UNITE4COVID launched to accelerate Cov..
05/13ROYAL DSM : Presentation to AGM
05/12ROYAL DSM : Ex-dividend day for final dividend (optional)
05/11ROYAL DSM : DSM boosts maternal and infant nutrition portfolio with new plant-ba..
More news
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 113,91 €
Last Close Price 115,10 €
Spread / Highest target 21,6%
Spread / Average Target -1,03%
Spread / Lowest Target -36,6%
EPS Revisions
Managers
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.-0.86%21 743
BASF SE-27.77%49 671
SHIN-ETSU CHEMICAL CO., LTD.4.48%48 729
DUPONT DE NEMOURS, INC.-20.75%37 226
FMC CORPORATION-0.94%12 739
GROUPE BRUXELLES LAMBERT-21.50%12 577